Johnson & Johnson reports Q1 2026 results, raises 2026 outlook
Go back to Johnson & Johnson reports Q1 2026 results, raises 2026 outlook| Johnson & Johnson (NYSE: JNJ) | Delayed: 278.43 +3.22 (1.17%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $275.21 | 52 Week High | $126.07 | |||
| Open | $277.32 | 52 Week Low | $94.28 | |||
| Day High | $278.89 | P/E | 57.89 | |||
| Day Low | $273.16 | EPS | $4.81 | |||
| Volume | 5,940,768 | |||||

